| Drug Name | Osimertinib |
|---|---|
| Other Drug Names | AZD-9291; Mereletinib; Tagrisso; AZD9291 |
| Chemical Name | N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide |
| Formula | C28H33N7O2 |
| Mol. Wt. | 499.61 |
| CAS No. | 1421373-65-0 |
| UNII | 3C06JJ0Z2O |
| Target-based Actions | Epidermal growth factor antagonist; Protein tyrosine kinase inhibitor |
| ATC Codes | L01XE35 |
| Highest Status | 批准上市 |
| Originator Company | AstraZeneca |
| Structure |
 |
Extended Information